Solingen Hospital Hosts Ecumenical Memorial for Lost Loved Ones
Solingen Hospital Hosts Ecumenical Memorial for Lost Loved Ones
Solingen Hospital Hosts Ecumenical Memorial for Lost Loved Ones
An ecumenical memorial service will be held at Solingen Municipal Hospital on Friday, November 21. The event aims to honour those who have passed away over the last year, offering a moment of reflection for relatives and hospital staff alike.
The service will take place in the hospital chapel at Gotenstraße 1, beginning at 5:00 PM. Protestant chaplain Renate Tomalik and Catholic pastoral caregiver Katrin Sühling will lead the gathering, providing support and guidance.
The chapel itself offers a dignified space for contemplation and comfort. Attendees will include family members and hospital employees who have lost loved ones or colleagues.
Assisting the chaplains will be the Green Ladies of the Ecumenical Hospital Aid. Their involvement ensures additional care and support for those in attendance.
The memorial service provides an opportunity for quiet remembrance within the hospital community. Relatives and staff are invited to attend, finding solace in a shared moment of reflection. No further details on attendance numbers or broader mortality trends have been provided.
Garlic, Vitamin C, and Chlorophyll Team Up for Heart Health Breakthrough
Could a simple blend of garlic, vitamin C, and chlorophyll be the key to a healthier heart? New findings reveal surprising benefits for blood pressure and beyond.
Chuck Norris, 86, hospitalized after medical emergency in Hawaii
From Walker, Texas Ranger to recent films, Norris never slowed down—until now. Fans worldwide await news after his sudden hospitalization.
Blood Test Breakthrough Could Detect Hidden Artery Disease Years Earlier
A simple blood test could soon reveal invisible plaque buildup—long before it triggers a deadly event. Machine learning cracked the code in 45,000 patients' data.
Eli Lilly's retatrutide shows groundbreaking results in Type 2 diabetes trial
A triple-hormone drug could redefine diabetes care. Early data shows retatrutide outperforms competitors—but will regulators agree?